发明名称 |
Methods of inhibiting activation of complement component C4 with anti-C1s antibodies |
摘要 |
The present disclosure provides antibodies that bind complement C1s protein; and nucleic acid molecules that encode such antibodies. The present disclosure also provides compositions comprising such antibodies, and methods to produce and use such antibodies, nucleic acid molecules, and compositions. |
申请公布号 |
US9074004(B2) |
申请公布日期 |
2015.07.07 |
申请号 |
US201414523093 |
申请日期 |
2014.10.24 |
申请人 |
TRUE NORTH THERAPEUTICS, INC. |
发明人 |
Van Vlasselaer Peter;Parry Graham;Stagliano Nancy E.;Panicker Sandip |
分类号 |
A61K39/395;C07K16/40;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Bozicevic, Field & Francis LLP |
代理人 |
Bozicevic, Field & Francis LLP ;Borden Paula A. |
主权项 |
1. A method of inhibiting activation of complement component C4 in an individual in need thereof, the method comprising administering to the individual a pharmaceutical composition comprising:
a pharmaceutically acceptable excipient suitable for administration to a human; and a humanized antibody that binds complement C1s protein and comprises light chain complementarity determining regions (CDRs) of an antibody light chain variable region comprising amino acid sequence SEQ ID NO:7 and heavy chain CDRs of an antibody heavy chain variable region comprising amino acid sequence SEQ ID NO:8. |
地址 |
South San Francisco CA US |